The emerging roles of YAP and TAZ in cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25592648.
- Also identified by DOI 10.1038/nrc3876 and PMC identifier 4562315.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) are the major downstream effectors of the Hippo pathway, which regulates tissue homeostasis, organ size, regeneration and tumorigenesis. In this Progress article, we summarize the current understanding of the biological functions of YAP and TAZ, and how the regulation of these two proteins can be disrupted in cancer. We also highlight recent findings on their expanding role in cancer progression and describe the potential of these targets for therapeutic intervention.
Medical subject headings
- Adaptor Proteins, Signal Transducing
- Cell Transformation, Neoplastic
- Intracellular Signaling Peptides and Proteins
- Neoplasms
- Phosphoproteins